Mesenchymal stem cells: In vitro differentiation among bone and cartilage cell lineages

Yakhteh

Volumn 9, Issue 3, 2007, Pages

  Eslaminejad, Mohamadreza Baghaban ^a   Yazdi, Poopak Eftekhari ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

Bone and cartilage differentiation; Culture condition; Mesenchymal stem cells; Signaling pathway

Indexed keywords

ASCORBIC ACID; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 9; DEXAMETHASONE; FK 506 BINDING PROTEIN; GLYCEROPHOSPHATE; INTERLEUKIN 1 RECEPTOR TYPE II; NERVE CELL ADHESION MOLECULE; PER1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN; ZINC FINGER PROTEIN;

BONE CELL; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PROTEIN FUNCTION; REVIEW;

EID: 38949094938     PISSN: 15614921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Fillip S, Mokry J, Hruska J. Adult stem cells and their importance in cell therapy. Folia Biologica 2003; 49: 9-14
2. Zech NH. Adult stem cell Manipulation and possible clinical perspectives. Repoduc Med Endocrinol 2004; 2: 91-99
3. Friedenstein AJ, Deriglasora UF, Kulagina NN, Panasuk AF, Rudakowa, Luria EA, Ruadkow IA. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay methods.Exp Hematol 1974; 2: 83-92
4. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panansyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hematopoietic tissues.Cloning in vitro and retransplantation in vivo. Transplantation 1974; 17: 331-40
5. Koc ON, Peters C, Aubourg P, Raghavan S, Dyhouse S, DeGasperi R, Kolodny EH, Yoseph YB, Gerson SL, Lazarus HM, Caplan AI, Watkins PA, Krivit W. Bone-marrow derived mesenchymal stem cells remained host-derived despite successful hematopoietic engraftment after allogenic transplantation in patient with lysosomal and peroxisomal storage diseases. EXP Hematol 1999; 27: 1675-1681
6. Awad HA, Butler DL, Boivine GP, Smith FN, Malaviya P, Huibregtse B, Caplan AI. Autologous mesenchymal stem cells mediated repair of tendon. Tissue Eng 1999; 5: 267-277
7. Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C, Hewett T, Chung T, Stock W, Sher D, Weissman S, Ferrer K, Mosca J, Deans R, Moseley A, Hoffman R. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 1999; 29: 244-255
8. Jessop HL, Noble BS, Cryer A. The differentiation of a potential mesenchymal stem cells population within ovine bone marrow. Biochem Soc Trans 1994; 22: 248
9. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997; 6:125-134
10. Martin DR, Cox NR, Hathcock TL, Niemeyer GP, Baker HJ: Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp Hematol 2002; 3: 879-886
11. Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang LC, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Bohnlein E, Storb R, Sandmaier BM. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop 2000; 379: 71-90
12. Ringe J, Kaps C, Schmitt B, Buscher K, Bartel J, Smolina H, Schultz O, Bumester GR, Haupl T, Sittinger M. Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res 2002; 307:321-327
13. Schwarz EJ, Alexander GM, Prockop DJ, Azizi SA: Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum. Gene Ther 1999:10:2539-2549
14. Meirelles LDS, Nardi NB. Murine marrow derived mesenchymal stem cell: Isolation, in vitro expansion, and characterization. Brit J Hemat 2003: 123: 702-711
15. Phinney DG, Kopen G, Isaacson RL, Prockop DJ:Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 1999; 72: 570-585
16. Badoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cellul Biochem2003; 89: 1235-1249
17. Eslaminejad MB, Nikmahzar A, Taghiyar L, Nadri S, Massumi M. Murine mesenchymal stem cells isolated by low density primary culture system. Dev Growth Differ 2006; 48: 361-370
18. Peister A, Mellad JA, Larsen LL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004; 103: 1662-1668
19. Tropel P, Noel D, Platet N, Legrand P, Benabid AL, Berger F. Isolation and characterization of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 2004; 295: 395-406
20. Van Vlasselaer P, Falla N, Snoeck H, Mathieu E: Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti sca-1 monoclonal antibody and wheat germ agglutinin. Blood 1994; 84: 753-763
21. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell physiol 1999; 181: 67-73
22. Piersma AH, Brockbank KG, Ploemacher RE, Van Vliet E, Brakel-van Peer KM Visser PJ. Characterization of fibroblastic stromal cells from murine bone marrow. Exp Hematol 1985; 13: 237-243
23. Prochop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissue. Science 1997; 276: 71-74
24. Bruder SP, Krause KH, Haynesworth SE. Growh kinetics, self-renewal, and the osteogenetic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 62: 247-294
25. Banfi A, Muraglia A, Dozin B, Mastro giacomo M,Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells amplication for their use in cell therapy.Exp Hematol 2000; 28: 707-715
26. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vivo according to hierarchial model. J Cell Sci 2000; 113: 1161-1166
27. Bianchi G, Muraglia A, Daga A, Corte G, Cancedda R, Quarto R. Microenvironment and stem properties of bone marrow derived mesenchymal cells. Wound Repair Regen 2001; 9: 460-466
28. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintainece of osteogenic precursures from human bone marrow. Endocrinology 1997; 138: 4456-4462
29. Tuan RS, Boland G, Tuli R. Adult stem cells and cell-based tissue egineering.Arthritis Res Ther 2003; 5: 32-45
30. Eslaminejad MB, Nadri S, Hajji Hosseini R. Expression of Thy 1.2 surface antigen increases significantly during the murine MSCs cultivation period. Develop. Growth Differ. 2007 49: 351-364
31. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Sciences 1999; 248: 143-147
32. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human marrow differentiation in vitro according to hierachial nodel. J Cell Sci 2000; 113: 1161-1166
33. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 3: 301-316
34. Takeuchi Y, Shibuya H, Gotoh Y, Matsumoto K, Kato S. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK 1/TAB 1/ NIK cascade. Nature cell Biol 2003; 5: 224-230
35. XU W, Zhaug X, Qian H, Sun W, Sun Y, Hu J, Zhou H, Chen Y. Mesenchymal stem cells from Adult human bone marrow differentiate in to cardiomyocyte phenotype in vitro. Exp Biol Med 2004; 229: 623-631
36. Wang PP, Wang JH, Yan P, Hu MY, Lau GK, Fan ST, Luk JM. Expression of hepatocyte-like phenotype in bone marrow stromal cells after HGF induction. Bioch Biophys Res commun 2004; 320: 712-716
37. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow stem cells in to pancreatic islet beta-cells. World J Gastroentrol 2004; 10: 3016-3020
38. Kotto DN, Ma By, Cardoso W, Sanderson EA, Summer RS, Williams M.C, Fine A. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001; 128: 1581-1588
39. Kicic A, Shen WY, Wilson AS, Constable IJ, Kobertson T, Rakoczy PE. Differentiation of marrow stromal cells into photoreceptors in the Rat eye. J Neursci 2003; 23: 7742-7749
40. Sugaya, K. Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases. Int Rev Cytol 2003; 228: 1-30
41. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, Mathieu E, Trompier F, Dudoignon N, Germain C, Mazurier C, Aigueperse J, Borneman J, Gorin NC, Gourmelon P, Thierry D. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene 2003; 5: 1028-1038
42. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004; 14: 1035-1041
43. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem cell 2004; 22: 487-500
44. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circulation Res 2002; 91: 1092-1102
45. Forbes SJ, Vig P, Poulsom R, Wright NA, Alison MR. Adult stem cell plasticity: new pathways of tissue regeneration become visible. Clini Sci 2002; 103: 355-369
46. Schwartz RE, Reyes M, Koodie L, Jiang y, Blackstad M, Lund T, Lenvik T, Johnson S, Hu W, Verfaillie M. Multipotent adult progenitor cells from bone marrow differentiate in to functional hepatocyte-like cells. J clini Investi 2002; 109: 1291-1302
47. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art and future trends: Macromol Biosci 2004; 9:743-765
48. Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H. Engineering bone: challenges and obstacles. J Cell Mol Med2005; 9:72-84
49. Rah DK. Art of replacing craniofacial bone defects. Yonsei 2000; 41:756-65
50. Hannouche D, Raould A, Nizard RS, Sedel L, Petite H. Embedding of bone samples in methylmethacrylate: A suitable method for tracking LacZ mesenchymal stem cells in skeletal Tissues. J Histochem Cytochem 2006; 55: 255-262
51. Shors EC. Coralline bone graft substitutes. Orthop Clin North Am 1999; 30: 599-613
52. Riminucci M, Banco P. Building bone tissue: matrices and scaffolds in physiology and biotechnology. Braz J Med Biol Res 2003; 36: 1027-36
53. Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004; 4: 290-294
54. Friedenstein AJ. Osteogenic stem cells in bone marrow. J of bone and Min Resear 1990; 7: 243-272
55. Bennett JH, Joyner CJ, Triffitt JT, Owen ME. Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 1991; 99:131-139
56. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992; 102:341-351
57. Gimble JM, Robinson CE, Wu X, Kelly KA. The function of adipocytes in the bone marrow stroma. Bone 1996; 19:421-428
58. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
59. Oyajobi BO, Lomri A, Hott M, Marie PJ. Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res 1999; 14:351-361
60. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999; 14: 700-709
61. Ahdjoudj S, Lasmoles F, Oyajobi BO, Lomri A, Delannoy P, Marie PJ. Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem 2001; 81: 23-38
62. Waterman-Storer CM, Karki SB, Kuznetsov SA, Tabb JS, Weiss DG, Langford GM, Holzbaur EL. The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. Proc Natl Acad Sci U S A. 1997; 94: 12180-12185
63. Ochi K, Wakisaka S, Youn SH, Hanada K, Maeda T. Calretinin-like immunoreactivity in the Ruffini endings, slowly adapting mechanoreceptors, of the periodontal ligament of the rat incisor. Brain Res 1997; 769: 183-187
64. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 1998; 142: 295-305
65. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 1995; 5: 571-576
66. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 1999; 14: 1522-1535
67. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 1999; 74: 357-371
68. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002; 143: 2376-84
69. Gimble JM, Robinson CE, Wu X, Kelly KA. The function of adipocytes in the bone marrow stroma: an update. Bone 1996; 19: 421-428
70. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004; 145: 401-406
71. Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B. Netoglitazone is a PPAR-gamma legand with selective effects on bone and fat. Bone 2006; 38: 74-84
72. Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005; 146: 1226-1235
73. Sottile V, Seuwen K, Kneissel M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPAR gamma agonist BRL49653 (rosiglitazone). Calcif Tissue Int 2004; 75: 329-337
74. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004; 113: 846-855
75. Marie PJ, Kaabeche K. PPAR Gamma Activity and Control of Bone Mass in Skeletal Unloading. PPAR Res 2006; 3: 64807
76. De Boer J, Wang HJ, Van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 2004; 10: 393-401
77. Boland GM, Perkins G, Hall D, Tuan RS. Wnt 3a promots proliferation and supressess differentiation of adult human mesenchymal stem cells.J Cell Biochem 2004; 15: 1210-1230
78. Eisenmann, DM. Wnt signaling, WormBook, ed. The C. elegans Research Community, WormBook, 2005; doi/10.1895/wormbook.1.7.1
79. Buckwalter JA. Articular cartilage injuries. Clin Orthop 2002; 402: 21-37
80. Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002; 3: 357-264
81. Buckwalter JA, mankin HJ. Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr course Lect 1998; 47: 487-504
82. Frenkel SR, Di cesare PE. Scaffolds for articular cartilage repair. Am Biomed Eng 2004; 32: 26-34
83. Hardingham T, Tew S, Murdoch A. Tissue engineering: chondrocytes and cartilage. Arthritis Res 2002; 4: 563-568
84. Mitchell N, Sheparol N. The resurfacing of adult rabbit articular cartilage by multiple perforations through the subchondral bone. J Bone joint surg Am 1976; 58: 230-233
85. Mankin H, Mow V, Buchwalter J. Form and function of articular cartilage. In: Simon S, ed. Orthopaedic Basic science. Rosemont IL: American Academy of orthopaedic surgeons 1994; 443-470
86. Frenkel SR, Clancy RM, Ricci JL, Di Cesare PE, Rediske JJ, Abramson SB. Effects of nitric oxide on chondrucyte migration, adhesion, and cytoskeletal assembly. Arthritis Rheum 1996; 39: 1905-1912
87. Manning WK, Bonner WMJR. Isolation and culture of chondrocytes from human adult articular cartilage. Arthritis Rheum 1967; 10: 235-239
88. Johnstone B. Mesenchymal stem cells and chondrogenesis. Europ Cell Mat 2002; 27
89. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow.Tissue Eng 1998; 4: 415-428
90. Carlberg AL, Pucci B, Rallapalli R, Tuan RS, Hall DJ. Efficient chondrogenesis of mesenchymal cells in micromass culture by retroviral gene transfer of BMP-2. Differentiation 2001; 67: 128-138
91. Bosnakovski D, Mizuno M, Kim G, Ishiguro T, Okumura M, Iwanaga T, Kadosawa T, Fujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells in pellet culture system.Exp Hematol 2004 ; 32: 502-509
92. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumur M, Fujinag T. Gene expression profile of bovine bone marrow mesenchymal stem cell during spontaneous chondrogenic differentiation in pellet culture system. JPN J Vet Res 2006; 53: 127-139
93. Indrawattana N, Chen G, Tadokoro M, Shann LH, Ohgushi H, Tateishi T, Tanaka J, Bunyaratvej A. Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun 2004; 320: 914-919
94. Yoo UY, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Jhonstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells.J Bone Joint Surg 1998; 12: 1745-1757
95. Eslaminejad MB, Nikmahzar A, Piriea A. The structure of human mesenchymal stem cells differentiated into cartilage in micro mass culture system.Yakhteh 2006; 8: 162-171
96. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells.Exp Cell Res 1998; 238: 265-275
97. Cassiede P, Dennis JE, Ma F, Caplan AI. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-β3 or PDGF-BB as assessed in vivo and in vitro. J Bone Miner Res 1996; 11: 1264-1273
98. Barry F, Boynton RE, Liu B, Murphy JM. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation dependent gene expression of matrix component. Exp Cell Res 2001; 268: 189-200
99. Macky AM, Beck SC, Murphy JM, Barry FP, Chester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998; 4: 415-428
100. Sekiya I, Colter DC, Prockop DJ. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun 2001; 284: 411-418
101. Majumdar MK, Wang E, Morris EA. BMP-2 and BMP-6 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes inhibitory effect of IL-1. J Cell Physiol 2001; 189: 275-284
102. Shea CM, Edgar CM, Einhorn TA, Gerstenfeld LC. BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis. J Cell Biochem 2003; 90: 1112-1127
103. Ma HL, Hung SC, Lin SY, Chen YL, Lo WH. Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads. J Biomed Mater Res 2003; 64: 273-281
104. Fukumoto T, Sperling JW, Sanyal A, Fitzsimmons JS, Reinholz GG, Conover CA, O'Driscoll SW. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 2003; 11: 55-64
105. Hatakeyama Y, Nguyen J, Wang X, Nuckolls GH, Shum L. Smad signaling in mesenchymal and chondroprogenitor cells. J Bone Joint Surg Am 2003; 85-A Suppl 3:13-18
106. Sanders MA, Basson MD. Collagen IV-dependent ERK activation in human Caco-2 intestinal epithelial cells requires focal adhesion kinase. J Biol Chem 2000; 275: 38040-38047
107. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F. P38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res 1999; 250: 351-363
108. Watanabe H, de Caestecker MP, Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 2001; 276: 14466-14473
109. Rudnicki JA, Brown AM. Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev Biol 1997; 185: 104-118
110. Tufan AC, Tuan RS. Wnt regulation of limb mesenchymal chondrogenesis is accompanied by altered N-cadherin-related functions. FASEB J 2001; 15: 1436-1438
111. Fischer L, Boland G, Tuan RS. Wnt 3a enhances bone morphogenetic proteins-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 2002; 277: 30B70-30B78